The impact of new therapies and technologies on health care includes numerous improvements to health outcomes, as well as an increase in cost and problems about access equality. New medicines, monitoring, and new healthcare enabling technology represent a once-in-a-generation potential to transform the lives of diabetics. These advancements allow for more accurate monitoring of blood glucose levels, as well as more precise insulin dose and administration. New insulins and delivery technologies are being developed to combat both hyperglycemia and hypoglycemia while also extending the time in range. There are already information systems that can be used to combine data from previously distinct systems into new models of connected care.